BASELINE CHARACTERISTICS OF PARTICIPANTS IN THE ANZDATA REGISTRY CLUSTER-RANDOMISED, SYMPTOM MONITORING WITH FEEDBACK TRIAL (SWIFT) FOR 2412 ADULTS RECEIVING FACILITY-BASED HAEMODIALYSIS

 

Certificate Output Instructions

For best output, select "Paper Size" as "A4" and "Margin" as "0" or "None".

To save or print to PDF, please select Print Destination > Save as PDF, enable Background Graphics under "More Settings", then click "Save".

 


 

Certificate Background

   

Presented the abstract " "
(Abstract co-author(s):  )

 

 

E-Poster Presentation

During the congress, E-Posters will be accessible to all participants on the congress website 24/7, as well as in the E-poster stations in the congress center. 

Preparing your E-Poster

Please review the E-Poster format requirements carefully when preparing your E-Poster. Should your E-Poster not meet the mentioned requirements, it may not be displayed as described above.

​E-Poster Submission Deadline

Please prepare and upload your E-Poster no later than March 14, 2026 11.59PM CET. After this date, you will no longer be able to prepare and upload your E-poster and it will not be displayed and accessible on the congress website.​

E-Poster Format Requirements
  • PDF file
  • Layout: Portrait (vertical orientation)
  • One page only (Dim A4: 210 x 297mm or PPT)
  • E-Poster can be prepared in PowerPoint (one (1) PowerPoint slide) but must be saved and submitted as PDF file.
  • File Size: Maximum file size is 2 Megabytes (2 MB)
  • No hyperlinks, animated images, animations, and slide transitions
  • Language: English
  • Include your abstract number
  • E-posters can include QR codes, tables and photos
https://storage.unitedwebnetwork.com/files/1099/c33471af6658cd1d91fb00e3e5542cd8.pdf
BASELINE CHARACTERISTICS OF PARTICIPANTS IN THE ANZDATA REGISTRY CLUSTER-RANDOMISED, SYMPTOM MONITORING WITH FEEDBACK TRIAL (SWIFT) FOR 2412 ADULTS RECEIVING FACILITY-BASED HAEMODIALYSIS

Please follow the instructions below to input your abstract title.

Abstract titles should be brief and reflect the content of the abstract.

  • The title will not be accepted if it exceeds 25 words.
  • Type in CAPITAL LETTERS.
  • Lowercase may be used for abbreviations only, for example, mRNA.
Stephen
McDonald
Rachael Morton rachael.morton@sydney.edu.au University of Sydney NHMRC Clinical Trials Centre Sydney Australia -
Chris Brown c.brown@sydney.edu.au University of Sydney NHMRC Clinical Trials Centre Sydney Australia -
Paul Bennett Paul.Bennett@unisa.edu.au University of South Australia ANZDATA Adelaide Australia -
Nicola Barrie nicola.barrie@sydney.edu.au University of Sydney NHMRC Clinical Trials Centre Sydney Australia -
William Handke bill.handke@gmail.com Consumer NHMRC Clinical Trials Centre Canberra Australia -
Brendan Smyth brendan.smyth@sydney.edu.au University of Sydney NHMRC Clinical Trials Centre Sydney Australia -
Andrea Viecelli andrea.viecelli@hin.ch University of Queensland Medicine Brisbane Australia -
Cecile Couchoud cecile.couchoud@biomedecine.fr Ministry of Health REIN Registry Paris France -
Fergus Caskey fergus.caskey@bristol.ac.uk University of Bristol Medicine Bristol United Kingdom -
Kathryn Ducharlet Kathryn.Ducharlet@easternhealth.org.au Eastern Health Renal Medicine Melbourne Australia -
Peter Mount peter.mount@austin.org.au Austin Health Renal Medicine Melbourne Australia -
David Johnson david.johnson2@health.qld.gov.au Princess Alexandra Hospital Renal Medcine Brisbane Australia -
David Harris david.harris@sydney.edu.au University of Sydney Medicine Sydney Australia -
Suetonia Palmer suetonia.palmer@otago.ac.nz University of Otago Medicine Christchurch New Zealand -
Stephen McDonald stephen@anzdata.org.au SAHMRI ANZDATA Adelaide Australia *